Cleared Traditional

K000375 - RANDOX CALCIUM

K000375 is the FDA 510(k) clearance for RANDOX CALCIUM by Randox Laboratories, Ltd.. It is a Class 2 Chemistry device (product code CIC) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K000375 · Randox Laboratories, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2000
Decision
58d
Days
Class 2
Risk

K000375 is an FDA 510(k) clearance for the RANDOX CALCIUM. Classified as Cresolphthalein Complexone, Calcium (product code CIC), Class II - Special Controls.

Submitted by Randox Laboratories, Ltd. (Crumlin, Co. Antrim, GB). The FDA issued a Cleared decision on April 5, 2000 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1145 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Randox Laboratories, Ltd. devices

Submission Details

510(k) Number K000375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 2000
Decision Date April 05, 2000
Days to Decision 58 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 88d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIC Cresolphthalein Complexone, Calcium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1145
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIC Cresolphthalein Complexone, Calcium

All 67
Devices cleared under the same product code (CIC) and FDA review panel - the closest regulatory comparables to K000375.
DIMENSION RXL MAX WITH ADVIA MODULAR AUTOMATION SYSTEM (AMAS)
K083339 · Siemens Healthcare Diagnostics, Inc. · Mar 2009
RAICHEM CALCIUM (OCPC) LIQUID REAGENT
K041009 · Hemagen Diagnostics, Inc. · Jun 2004
COBAS INTEGRA REAGENT CASSETTES & ANCILLARY REAGENTS
K963292 · Roche Diagnostic Systems, Inc. · Oct 1996
CALCIUM REAGENT
K944258 · Olympus America, Inc. · Jan 1995
IL TEST CALCIUM
K931362 · Instrumentation Laboratory CO · Feb 1994
CALCIUM TEST ITEM NUMBER 65409
K932158 · Em Diagnostic Systems, Inc. · Sep 1993